BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 21725661)

  • 1. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
    Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
    J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New methodological advances: algorithm proposal for management of Clostridium difficile infection].
    González-Abad MJ; Alonso-Sanz M
    Rev Esp Quimioter; 2015 Jun; 28(3):157-9. PubMed ID: 26033001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
    Snell H; Ramos M; Longo S; John M; Hussain Z
    J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative performance of the GeneXpert C. difficile PCR assay and C. diff Quik Chek Complete kit assay for detection of Clostridium difficile antigen and toxins in symptomatic community-onset infections.
    Jamal W; Pauline EM; Rotimi VO
    Int J Infect Dis; 2014 Dec; 29():244-8. PubMed ID: 25462186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with laboratory diagnosis of Clostridium difficile].
    Bareková L; Zálabská E; Hanovcová I
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):91-5. PubMed ID: 24579451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea.
    Moon HW; Kim HN; Hur M; Shim HS; Kim H; Yun YM
    PLoS One; 2016; 11(8):e0161139. PubMed ID: 27532104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.
    Akamatsu Y; Morishita S; Chikumi H; Okamoto R; Okada K; Kitaura T; Miyake N; Yamaguchi K; Nakamoto M; Shimohiro H; Takata M; Yamasaki A; Burioka N; Shimizu E
    J Med Invest; 2018; 65(1.2):131-135. PubMed ID: 29593183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis of clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory.
    Wren MW; Sivapalan M; Kinson R; Shetty NR
    Br J Biomed Sci; 2009; 66(1):1-5. PubMed ID: 19348118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases.
    Barbut F; Lalande V; Daprey G; Cohen P; Marle N; Burghoffer B; Petit JC
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):481-4. PubMed ID: 10947228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection.
    Kim H; Kim WH; Kim M; Jeong SH; Lee K
    Ann Lab Med; 2014 May; 34(3):235-9. PubMed ID: 24790912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of infections caused by Clostridium difficile in the Czech Republic: availability, possibilities, and interpretation of laboratory results].
    Krůtová M; Nyč O
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):92-7. PubMed ID: 26099613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory comparison between cell cytotoxicity neutralization assay and ultrasensitive single molecule counting technology for detection of Clostridioides difficile toxins A and B, PCR, enzyme immunoassays, and multistep algorithms.
    Sandlund J; Mills R; Griego-Fullbright C; Wagner A; Estis J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Nolan N; Bishop JJ; Todd J; Young S
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):20-24. PubMed ID: 31129008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the VIDAS glutamate dehydrogenase assay for the detection of Clostridium difficile.
    Shin BM; Lee EJ; Moon JW; Lee SY
    Anaerobe; 2016 Aug; 40():68-72. PubMed ID: 27282799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.